Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $53.74 in the prior trading day, Bio-Techne Corp (NASDAQ: TECH) closed at $53.6, down -0.26%. In other words, the price has decreased by -$0.26 from its previous closing price. On the day, 1.31 million shares were traded. TECH stock price reached its highest trading level at $54.38 during the session, while it also had its lowest trading level at $53.39.
Ratios:
Our goal is to gain a better understanding of TECH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 51.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.85. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 3.46. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.22.
On July 09, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $65.
On May 30, 2025, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $59.Wells Fargo initiated its Overweight rating on May 30, 2025, with a $59 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’25 when Herr Amy E. sold 1,280 shares for $49.77 per share. The transaction valued at 63,705 led to the insider holds 1,976 shares of the business.
JOSHUA MOLHO bought 1,280 shares of TECH for $63,705 on Jun 09 ’25. On Feb 14 ’25, another insider, Herr Amy E., who serves as the Director of the company, sold 1,860 shares for $65.96 each. As a result, the insider received 122,691 and left with 1,976 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TECH now has a Market Capitalization of 8402711552 and an Enterprise Value of 8585208832. As of this moment, Bio-Techne’s Price-to-Earnings (P/E) ratio for their current fiscal year is 118.14, and their Forward P/E ratio for the next fiscal year is 23.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.89 while its Price-to-Book (P/B) ratio in mrq is 4.16. Its current Enterprise Value per Revenue stands at 7.039 whereas that against EBITDA is 36.846.
Stock Price History:
The Beta on a monthly basis for TECH is 1.46, which has changed by -0.28523803 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, TECH has reached a high of $80.95, while it has fallen to a 52-week low of $46.01. The 50-Day Moving Average of the stock is 1.91%, while the 200-Day Moving Average is calculated to be -12.64%.
Shares Statistics:
The stock has traded on average 2.32M shares per day over the past 3-months and 2477230 shares per day over the last 10 days, according to various share statistics. A total of 156.77M shares are outstanding, with a floating share count of 154.96M. Insiders hold about 1.15% of the company’s shares, while institutions hold 102.09% stake in the company. Shares short for TECH as of 1753920000 were 6335952 with a Short Ratio of 2.74, compared to 1751241600 on 6315794. Therefore, it implies a Short% of Shares Outstanding of 6335952 and a Short% of Float of 4.64.
Dividends & Splits
In the trailing 12 months, TECH’s forward annual dividend rate was 0.32, compared to 0.32 this year. Against a Trailing Annual Dividend Yield of 0.0059545957The stock’s 5-year Average Dividend Yield is 0.41. The current Payout Ratio is 69.57% for TECH, which recently paid a dividend on 2025-05-19 with an ex-dividend date of 2025-08-18. Stock splits for the company last occurred on 2022-11-30 when the company split stock in a 4:1 ratio.
Earnings Estimates
The stock of Bio-Techne Corp (TECH) is currently being evaluated by 13.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.46, with high estimates of $0.49 and low estimates of $0.43.
Analysts are recommending an EPS of between $2.07 and $1.91 for the fiscal current year, implying an average EPS of $2.01. EPS for the following year is $2.24, with 12.0 analysts recommending between $2.44 and $2.01.
Revenue Estimates
13 analysts predict $293.06M in revenue for the current quarter. It ranges from a high estimate of $298M to a low estimate of $289.52M. As of the current estimate, Bio-Techne Corp’s year-ago sales were $289.46MFor the next quarter, 13 analysts are estimating revenue of $300.69M. There is a high estimate of $309.5M for the next quarter, whereas the lowest estimate is $296.13M.
A total of 15 analysts have provided revenue estimates for TECH’s current fiscal year. The highest revenue estimate was $1.26B, while the lowest revenue estimate was $1.23B, resulting in an average revenue estimate of $1.24B. In the same quarter a year ago, actual revenue was $1.22BBased on 12 analysts’ estimates, the company’s revenue will be $1.33B in the next fiscal year. The high estimate is $1.36B and the low estimate is $1.29B.
